The emerging role of miR-128 in musculoskeletal diseases

Qi Shang1,2, Gengyang Shen2,3, Guifeng Chen1,2

  • 1The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.

Insights

MicroRNA-128 (miR-128) is crucial for bone metabolism and skeletal muscle regeneration. Its deregulation is linked to musculoskeletal diseases, suggesting miR-128 as a potential therapeutic target.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Regenerative Medicine

Background:

  • MicroRNA-128 (miR-128) plays a role in cellular processes like proliferation, differentiation, migration, apoptosis, and survival.
  • Genetic studies indicate miR-128 involvement in bone metabolism, including mesenchymal stem cells, osteoblasts, osteoclasts, and adipocytes.
  • miR-128 is also implicated in skeletal muscle regeneration through its targeting of myoblast-associated proteins.

Purpose of the Study:

  • To review recent findings on miR-128's role in bone metabolism and muscle regeneration.
  • To explore the potential therapeutic applications of miR-128 in musculoskeletal diseases.
  • To suggest future research directions in this field.

Main Methods:

  • Literature review of genetic analysis studies and recent findings.
  • Analysis of miR-128's involvement in cellular processes.
  • Examination of miR-128's targets in bone and muscle tissues.

Main Results:

  • miR-128 is a key regulator in bone metabolism and skeletal muscle regeneration.
  • Deregulation of miR-128 is associated with the development of musculoskeletal disorders.
  • miR-128 influences critical cell types and proteins involved in bone and muscle health.

Conclusions:

  • miR-128 holds significant therapeutic potential for treating musculoskeletal diseases.
  • Further research into miR-128 mechanisms could unlock novel treatment strategies.
  • Understanding miR-128's function is vital for advancing musculoskeletal health research.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.2K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.5K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.5K